Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neuroblastoma 5Recurrence 2Multiple Myeloma 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Transplant-Related Hematologic Malignancy 1Stomatitis 1Oligodendroglioma 1Neoplasms 1Nasopharyngeal Carcinoma 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Carcinoma, Intraductal, Noninfiltrating 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 4Specimen Handling 3Cyclophosphamide 3Biopsy 3sodium-iodide symporter 2fludarabine 2cemiplimab 2alectinib 2X-Rays 2Stem Cell Transplantation 2Photons 2Nivolumab 2Immunoglobulin G 2Disulfides 2treosulfan 1sargramostim 1ruxolitinib 1repotrectinib 1duvelisib 1brigatinib 1belinostat 1Whole-Body Irradiation 1Vinblastine 1Suspensions 1Standard of Care 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Mycophenolic Acid 1Leukapheresis 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, Large-Cell, Anaplastic × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT05544968 2026-04-03

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Medical College of Wisconsin

Phase 1 Recruiting
42 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Neoplasms, Recurrence, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡